Inventor profile of:

Peter Richardson

City:

Ringoes, New Jersey

Country:

United States

Published Applications:

25

Last publication date:

2024-06-20

Top Assignees for applications by Peter Richardson

The entities that hold a legal rights for patent applications filed by inventor Richardson Peter:

Recent patent applications by Richardson Peter

Peter Richardson from Ringoes, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-06-20
US20240197836A1
Human necessities

METHOD OF TREATING DIABETES TYPE 2 BY ADMINISTERING ULTRARAPID ACTING INSULIN

#2 | 2024-06-20
US20240197627A1
Human necessities

DELIVERY OF ACTIVE AGENTS

#3 | 2023-09-21
US20230293436A1
Human necessities

Inhalable dry powder pharmaceutical composition

#4 | 2022-12-08
US20220387593A1
Human necessities

METHOD OF PREVENTING ADVERSE EFFECTS BY GLP-1

#5 | 2022-11-17
US20220362147A1
Human necessities

Delivery of Active Agents

#6 | 2021-05-13
US20210138040A1
Human necessities

Method of treating diabetes type 2 by administering ultrarapid acting insulin

#7 | 2020-05-14
US20200147219A1
Human necessities

METHOD OF PREVENTING ADVERSE EFFECTS BY GLP-1

#8 | 2020-05-14
US20200147180A1
Human necessities

Inhalable dry powder pharmaceutical composition

#9 | 2020-05-14
US20200146981A1
Human necessities

DELIVERY OF ACTIVE AGENTS

#10 | 2019-06-06
US20190167580A1
Human necessities

Delivery of Active Agents

#11 | 2018-07-05
US20180185453A1
Human necessities

Method of treating diabetes type 2 by administering ultrarapid acting insulin

#12 | 2017-10-26
US20170304404A1
Human necessities

METHOD FOR TREATING HYPERGLYCEMIA WITH GLP-1

#13 | 2015-10-08
US20150283213A1
Human necessities

METHOD FOR TREATING HYPERGLYCEMIA WITH GLP-1

#14 | 2015-03-19
US20150080298A1
Human necessities

METHOD FOR TREATING HYPERGLYCEMIA

#15 | 2014-07-03
US20140187490A1
Chemistry; metallurgy

Val (8) GLP-1 Composition and Method for Treating Functional Dyspepsia and/or Irritable Bowel Syndrome

#16 | 2014-04-10
US20140100158A1
Human necessities

Use of ultrarapid acting insulin

#17 | 2013-05-23
US20130125886A1
Human necessities

METHOD OF PREVENTING ADVERSE EFFECTS BY GLP-1

#18 | 2013-05-16
US20130118491A1
Human necessities

Delivery of Active Agents

#19 | 2012-10-04
US20120252728A1
Chemistry; metallurgy

Val (8) GLP-1 composition and method for treating functional dyspepsia and/or irritable bowel syndrome

#20 | 2012-05-10
US20120115777A1
Human necessities

Method of treating diabetes type 2 by administering ultrarapid acting insulin

#21 | 2012-04-19
US20120094905A1
Human necessities

Method for treating hyperglycemia with GLP-1

#22 | 2012-02-16
US20120040899A1
Human necessities

Method for treating hyperglycemia

#23 | 2010-02-11
US20100035794A1
Human necessities

Method of treating diabetes type 2 by metformin and an ultrarapid acting insulin

#24 | 2009-04-30
US20090111749A1
Human necessities

Delivery of active agents

#25 | 2009-04-30
US20090110647A1
Human necessities

Method of preventing adverse effects by GLP-1

InventorID:

240648 ⎘